Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107481 · ClinicalTrials.gov registry record · Phase 4
Acetaminophen IV vs Hydromorphone IV in the ED
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 220
- Enrollment target
NCT03107481: Completed Phase 4 study, sponsored by Montefiore Medical Center.
NCT03107481 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 220 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03107481, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 220 participants
- Enrollment target
Study Summary
The purpose of the current study is to compare the analgesic efficacy of intravenous acetaminophen and intravenous hydromorphone in the treatment of acute pain in the ED.
Primary Outcome
Between group difference in change in NRS pain scores from baseline
Interventions
- DRUG Acetaminophen
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2017-06-04 |
| Est. Completion | 2017-11-14 |
| Phase | Phase 4 |
What the finished NCT03107481 record still lists
NCT03107481 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT03107481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03107481 about?
NCT03107481 is a clinical study titled "Acetaminophen IV vs Hydromorphone IV in the ED". The purpose of the current study is to compare the analgesic efficacy of intravenous acetaminophen and intravenous hydromorphone in the treatment of acute pain in the ED.
What is the current status of trial NCT03107481?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2017-06-04. Estimated completion is 2017-11-14.
What interventions are being tested in trial NCT03107481?
The interventions under investigation include: Acetaminophen (DRUG), Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT03107481?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03107481's enrollment target sits among peer trials
220 385th of 2000 higher than 1,612 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI